The Role of CD30 Overexpression in CD30-positive Non-Hodgkins Lymphomas [ 2008 - 2010 ]

Also known as: CD30 Expression in Cancer

Research Grant

[Cite as]

Researchers: Prof Lawrence Abraham (Principal investigator) ,  Prof George Yeoh

Brief description The CD30 molecule sits on the surface of normal blood cells, but in a type of cancer called Lymphoma, CD30 concentration is high. The level of expression of CD30 may determine if the cancer cell is killed by the normal defense mechanisms or is able to grow uncontrollably. We are studying the control elements of the CD30 gene to understand how control is lost when the cell becomes cancerous. This knowledge may lead to therapeutic strategies to control lymphoma.

Funding Amount $AUD 457,242.67

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]